European Expert Group on Orphan Drug Incentives unveils policy proposals to address unmet needs in rare diseases along the orphan drug development path
The multidisciplinary European Expert Group on Orphan Drug Incentives has developed fourteen innovative proposals along the entire lifecycle of orphan drug development to address the huge unmet needs in rare diseases. With over ninety percent of patients without a centrally approved treatment option, the need for innovation and research into orphan drugs is immense.
Read our full Press Release: 2021-06-11 Press Release OD Expert Group
Posted on 11. June 2021